Sign In
Buy OPRX
$6.05
-0.220 (-3.51%)
At Close: Jul 31, 2026
Brokerages Set OptimizeRx Corp. (NASDAQ:OPRX) Price Target at $21.00
01:46am, Tuesday, 10'th Feb 2026
OptimizeRx Corp. (NASDAQ: OPRX - Get Free Report) has earned a consensus recommendation of "Moderate Buy" from the nine ratings firms that are covering the firm, Marketbeat.com reports. One analyst ha
OptimizeRx Sets Fourth Quarter and Full Year 2025 Financial Results Conference Call for March 5, 2026, at 4:30 p.m. ET
08:00am, Thursday, 05'th Feb 2026
WALTHAM, Mass., Feb. 05, 2026 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and e
Strength Seen in OptimizeRx (OPRX): Can Its 7.5% Jump Turn into More Strength?
07:35am, Thursday, 05'th Feb 2026
OptimizeRx (OPRX) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase
OptimizeRx and Experian Collaborate to Improve Privacy-Safe Identity Resolution in Healthcare Marketing
08:00am, Wednesday, 07'th Jan 2026
WALTHAM, Mass., Jan. 07, 2026 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life science companies reach and en
OptimizeRx Stock: A Buy-The-Dip Opportunity For This Above-Average Growth Story
10:03am, Tuesday, 23'rd Dec 2025
OptimizeRx's Q3 2025 results reinforce my long-term bullish thesis. OPRX demonstrates continued operational momentum, supporting confidence in sustained growth. Recent earnings solidify conviction in
OptimizeRx (NASDAQ:OPRX) Insider Edward Stelmakh Sells 1,388 Shares of Stock
05:01am, Tuesday, 23'rd Dec 2025
OptimizeRx Corp. (NASDAQ: OPRX - Get Free Report) insider Edward Stelmakh sold 1,388 shares of OptimizeRx stock in a transaction dated Friday, December 19th. The stock was sold at an average price of
OptimizeRx Continues Expansion of the Company's Point-Of-Care Network
04:30am, Wednesday, 17'th Dec 2025
WALTHAM, Mass., Dec. 17, 2025 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and e
New Strong Buy Stocks for Nov. 17: ROKU, AVPT, and More
07:52am, Monday, 17'th Nov 2025
ROKU, AVPT, ETOR, NRIM and OPRX have been added to the Zacks Rank #1 (Strong Buy) List on November 17, 2025.
OptimizeRx Corporation (OPRX) Q3 2025 Earnings Call Transcript
05:56am, Friday, 07'th Nov 2025
OptimizeRx Corporation ( OPRX ) Q3 2025 Earnings Call November 6, 2025 4:30 PM EST Company Participants Stephen Silvestro - President & CEO Edward Stelmakh - Chief Financial & Strategic Officer Andrew
OptimizeRx Corp. (OPRX) Tops Q3 Earnings and Revenue Estimates
07:16pm, Thursday, 06'th Nov 2025
OptimizeRx Corp. (OPRX) came out with quarterly earnings of $0.2 per share, beating the Zacks Consensus Estimate of $0.03 per share. This compares to earnings of $0.12 per share a year ago.
OptimizeRx Reports Third Quarter 2025 Financial Results and Increases Fiscal Year 2025 Guidance
04:01pm, Thursday, 06'th Nov 2025
- Q3 revenue of $26.1 million, increased 22% year-over-year- Q3 gross profit increased 30% year-over-year to $17.5 million- Increases full year 2025 guidance to a revenue range between $10
OptimizeRx Sets Third Quarter 2025 Conference Call for November 6, 2025, at 4:30 p.m. ET
08:00am, Monday, 20'th Oct 2025
WALTHAM, Mass., Oct. 20, 2025 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and e
4 Top AI-Powered Healthcare Stocks
05:00am, Thursday, 09'th Oct 2025
Healthcare stocks quietly outperformed the market in the past 30 days as headlines centered on the government shutdown over the extension of Affordable Care Act tax credits for 2026. The AI in healthc
OptimizeRx: How The Stock Is Changing Pharma Marketing
10:02pm, Tuesday, 07'th Oct 2025
OptimizeRx Corporation is evolving from an EHR messaging platform to a clinical data and AI-driven advertising company, leveraging DAAP and MNT technologies. Q2 2025 financials show strong revenue gro
OptimizeRx Corp. (OPRX) is a Great Momentum Stock: Should You Buy?
01:01pm, Thursday, 02'nd Oct 2025
Does OptimizeRx Corp. (OPRX) have what it takes to be a top stock pick for momentum investors? Let's find out.
